Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paulina Rampetsreiter1, Emilio Casanova, Robert Eferl

  • 1Ludwig Boltzmann Institute for Cancer Research (LBI-CR) , Währinger Strasse 13a, A-1090 Vienna, Austria.

Drug Discovery Today. Disease Models
|May 12, 2012
PubMed
Summary
This summary is machine-generated.

Cancer cells must adapt to survive and spread to distant sites. This review examines genetically engineered mouse models (GEMMs) to understand the molecular mechanisms of tumor invasion and metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and Treatment.

Exploration of digestive diseases·2026
Same author

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Cancer letters·2026
Same author

KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors.

NPJ precision oncology·2026
Same author

STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts.

Cell reports·2025
Same author

Quantitative Proteomics Identifies Potential Molecular Adaptations in Mouse Models of Congenital Stationary Night Blindness Type 2.

Molecular & cellular proteomics : MCP·2025
Same author

A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis.

Science (New York, N.Y.)·2025
Same journal

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024
Same journal

Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery.

Drug discovery today. Disease models·2021
Same journal

Epstein-Barr Virus Infection in the Development of Neurological Disorders.

Drug discovery today. Disease models·2021
Same journal

Applying the 3Rs to non-human primate research: Barriers and solutions.

Drug discovery today. Disease models·2021
Same journal

<i>In vitro</i> models of HIV-1 infection of the Central Nervous System.

Drug discovery today. Disease models·2021
Same journal

Chediak-Higashi syndrome: a review of the past, present, and future.

Drug discovery today. Disease models·2021
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor invasion and metastasis are critical determinants of cancer patient mortality.
  • Understanding cancer cell adaptation during metastasis is crucial for developing effective treatments.

Purpose of the Study:

  • To review genetically engineered mouse models (GEMMs) used for studying cancer invasion and metastasis.
  • To highlight the utility of GEMMs in elucidating molecular mechanisms of metastasis.

Main Methods:

  • Assessment of existing literature on genetically engineered mouse models (GEMMs).
  • Analysis of how GEMMs facilitate the study of cancer cell adaptation and spread.

Main Results:

  • GEMMs provide powerful tools to investigate the complex molecular processes of cancer metastasis.

Related Experiment Videos

  • These models allow for in vivo studies of cancer cell adaptation to microenvironments encountered during metastasis.

    • Conclusions:

    • Genetically engineered mouse models are invaluable for dissecting the mechanisms of tumor invasion and metastasis.
    • Further research using GEMMs will advance our understanding of metastatic disease and inform therapeutic strategies.